HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A corrigendum has been published All Versions of this Article: 292/1/H66    most recent 00312.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Clancy, C. E. Articles by Rudy, Y. Search for Related Content PubMed PubMed Citation Articles by Clancy, C. E. Articles by Rudy, Y.

CALL FOR PAPERS
Computational Analyses in Ion Channelopathies

Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation

¹Department of Physiology and Biophysics, Institute for Computational Biomedicine, Weill Medical College of Cornell University, New York, New York; and ²Washington University in St. Louis, Cardiac Bioelectricity and Arrhythmia Center, St. Louis, Missouri

Submitted 27 March 2006 ; accepted in final form 19 September 2006

Pharmacological management of cardiac arrhythmias has been a long and widely sought goal. One of the difficulties in treating arrhythmia stems, in part, from incomplete understanding of the mechanisms of drug block and how intrinsic properties of channel gating affect drug access, binding affinity, and unblock. In the last decade, a plethora of genetic information has revealed that genetics may play a critical role in determining arrhythmia susceptibility and in efficacy of pharmacological therapy. In this context, we present a theoretical approach for investigating effects of drug-channel interaction. We use as an example open-channel or inactivated-channel block by the local anesthetics mexiletine and lidocaine, respectively, of normal and KPQ mutant Na⁺ channels associated with the long-QT syndrome type 3. Results show how kinetic properties of channel gating, which are affected by mutations, are important determinants of drug efficacy. Investigations of Na⁺ channel blockade are conducted at multiple scales (single channel and macroscopic current) and, importantly, during the cardiac action potential (AP). Our findings suggest that channel mean open time is a primary determinant of open state blocker efficacy. Channels that remain in the open state longer, such as the KPQ mutant channels in the abnormal burst mode, are blocked preferentially by low mexiletine concentrations. AP simulations confirm that a low dose of mexiletine can remove early afterdepolarizations and restore normal repolarization without affecting the AP upstroke. The simulations also suggest that inactivation state block by lidocaine is less effective in restoring normal repolarization and adversely suppresses peak Na⁺ current.

cardiac arrhythmias; sodium channel; theoretical model; Markov model; genetic mutations; channelopathies; computational biology; pharmacology; long-QT syndrome

This article has been cited by other articles:

				L. Romero, E. Pueyo, M. Fink, and B. Rodriguez Impact of ionic current variability on human ventricular cellular electrophysiology Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1436 - H1445. [Abstract] [Full Text] [PDF]

				R. C. Ahrens-Nicklas, C. E. Clancy, and D. J. Christini Re-evaluating the efficacy of {beta}-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling Cardiovasc Res, June 1, 2009; 82(3): 439 - 447. [Abstract] [Full Text] [PDF]